Deutsche Bank’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-212,944
| Closed | -$183K | – | 3627 |
|
|
2023
Q4 | $183K | Buy |
+212,944
| New | +$183K | ﹤0.01% | 2885 |
|
|
2023
Q3 | – | Sell |
-231,917
| Closed | -$601K | – | 3817 |
|
|
2023
Q2 | $601K | Sell |
231,917
-6,599
| -3% | -$17.1K | ﹤0.01% | 2253 |
|
|
2023
Q1 | $973K | Sell |
238,516
-5,339
| -2% | -$21.8K | ﹤0.01% | 2118 |
|
|
2022
Q4 | $1.22M | Sell |
243,855
-18,996
| -7% | -$95.4K | ﹤0.01% | 1924 |
|
|
2022
Q3 | $3.44M | Sell |
262,851
-1,061
| -0.4% | -$13.9K | ﹤0.01% | 1364 |
|
|
2022
Q2 | $3.38M | Buy |
263,912
+92,018
| +54% | +$1.18M | ﹤0.01% | 1480 |
|
|
2022
Q1 | $2.62M | Buy |
171,894
+3,650
| +2% | +$55.7K | ﹤0.01% | 1732 |
|
|
2021
Q4 | $2.98M | Sell |
168,244
-7,991
| -5% | -$141K | ﹤0.01% | 1743 |
|
|
2021
Q3 | $3.71M | Buy |
176,235
+23,381
| +15% | +$492K | ﹤0.01% | 1687 |
|
|
2021
Q2 | $3.01M | Sell |
152,854
-111,848
| -42% | -$2.21M | ﹤0.01% | 1862 |
|
|
2021
Q1 | $7.69M | Buy |
264,702
+246,926
| +1,389% | +$7.18M | ﹤0.01% | 1319 |
|
|
2020
Q4 | $539K | Buy |
17,776
+4,786
| +37% | +$145K | ﹤0.01% | 2835 |
|
|
2020
Q3 | $207K | Buy |
12,990
+1,136
| +10% | +$18.1K | ﹤0.01% | 3161 |
|
|
2020
Q2 | $234K | Buy |
11,854
+2,057
| +21% | +$40.6K | ﹤0.01% | 3027 |
|
|
2020
Q1 | $121K | Buy |
9,797
+819
| +9% | +$10.1K | ﹤0.01% | 3128 |
|
|
2019
Q4 | $165K | Buy |
8,978
+6,955
| +344% | +$128K | ﹤0.01% | 3284 |
|
|
2019
Q3 | $26K | Sell |
2,023
-1,366
| -40% | -$17.6K | ﹤0.01% | 4068 |
|
|
2019
Q2 | $49K | Buy |
+3,389
| New | +$49K | ﹤0.01% | 4307 |
|